KLF2 and COVID-19: We also observed that adenovirus mediated KLF2 overexpression or atorvastatin reversed COVID-19-patient-serum-induced monocyte adhesion to endothelial cells, suggesting that pharmacological activation of KLF2 could be a viable strategy of ameliorating endothelial dysfunction in COVID-19.